T1	Participants 231 260	patients with type 2 diabetes
T2	Participants 355 418	patients with type 2 diabetes with suboptimal metabolic control
T3	Participants 420 488	Patients with a baseline haemoglobin A(1c) (HbA(1c)) of 7.3 to 11.0%
